Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

(2011) F. K. Engels et al.   CLINICAL CANCER RESEARCH

Making the Investigational Oncology Pipeline More Efficient and Effective: Are We Headed in the Right Direction?

(2010) P. M. LoRusso et al.   CLINICAL CANCER RESEARCH

Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

(2010) L. Bonilla et al.   JNCI-Journal of the National Cancer Institute

Model-Based Neutrophil-Guided Dose Adaptation in Chemotherapy: Evaluation of Predicted Outcome with Different Types and Amounts of Information

(2009) Johan E. Wallin et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Population Pharmacokinetics and Pharmacodynamics for Treatment Optimization??in Clinical Oncology

(2008) Anthe S Zandvliet et al.   CLINICAL PHARMACOKINETICS

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

(2008) Martine J. Piccart-Gebhart et al.   JOURNAL OF CLINICAL ONCOLOGY